celecoxib has been researched along with Keratoacanthoma in 1 studies
Keratoacanthoma: A benign, non-neoplastic, usually self-limiting epithelial lesion closely resembling squamous cell carcinoma clinically and histopathologically. It occurs in solitary, multiple, and eruptive forms. The solitary and multiple forms occur on sunlight exposed areas and are identical histologically; they affect primarily white males. The eruptive form usually involves both sexes and appears as a generalized papular eruption.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Keratoacanthomas (KAs) and cutaneous squamous cell carcinomas (cuSCCs) develop in 15-30% of patients with BRAF(V600E) metastatic melanoma treated with BRAF inhibitors (BRAFi)." | 1.40 | COX-2 inhibition prevents the appearance of cutaneous squamous cell carcinomas accelerated by BRAF inhibitors. ( Atefi, M; Avramis, E; Cass, A; Cochran, AJ; Comin-Anduix, B; Escuin-Ordinas, H; Fu, Y; Graeber, TG; Herschman, HR; Huang, RR; Lo, RS; Marais, R; Ng, C; Ribas, A; Yashar, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Escuin-Ordinas, H | 1 |
| Atefi, M | 1 |
| Fu, Y | 1 |
| Cass, A | 1 |
| Ng, C | 1 |
| Huang, RR | 1 |
| Yashar, S | 1 |
| Comin-Anduix, B | 1 |
| Avramis, E | 1 |
| Cochran, AJ | 1 |
| Marais, R | 1 |
| Lo, RS | 1 |
| Graeber, TG | 1 |
| Herschman, HR | 1 |
| Ribas, A | 1 |
1 other study available for celecoxib and Keratoacanthoma
| Article | Year |
|---|---|
COX-2 inhibition prevents the appearance of cutaneous squamous cell carcinomas accelerated by BRAF inhibitors.
Topics: Animals; Carcinoma, Squamous Cell; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Female; | 2014 |